Specific Acute Inflammatory Responses

  • M. W. Greaves
  • F. Lawlor
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 1)


Although inflammation is the major component of some dermatological disorders, it is also an important though subsidiary component of many more. The skin shows striking clinical and histopathological specificity, compared with other organs and tissues, in its reponse to injury. It is capable of responding to different forms of injury in widely varying ways, ranging from erytheme and wealing to blister formation, reactions seen in no other organ or tissue surfaces. Itching is also a symptom of inflammation unique to the skin. At a microscopic level the skin also manifests a striking cellular reaction, seen in no other tissue, called spongiosis, i.e. intercellular oedema. Although the pharmacological events occurring in inflamed skin and in other tissues show points of similarity, it is not surprising that there are also major differences. It is imortant to attempt to understand these differences, not only in order to appreciate the pathophysiology of inflammatory skin disorders but also for the sake of future progress in developing innovative drug treatment for these conditions.


Arachidonic Acid Atopic Dermatitis Allergic Contact Dermatitis Chronic Urticaria High Performance Liquid Chro 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arturson G, Hamberg M, Jonson CE (1973) Prostaglandins in human burn blister fluid. Acta Physiol Scand 87:270–276PubMedCrossRefGoogle Scholar
  2. Black AK, Greaves MW, Hensby CN, Plummer NA, Warin AP (1978) The effects of indomethacin on arachidonic acid and prostaglandins E2 and F2α levels in human skin 24 h after UV-B and UV-C irradiation. Br J Clin Pharmacol 6:261–266PubMedGoogle Scholar
  3. Black AK, Fincham N, Greaves MW, Hensby CN (1980) Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2α in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 10:453–157PubMedGoogle Scholar
  4. Black AK, Keahey TM, Eady RAJ, Greaves MW (1981) Dissociation of histamine release and clinical improvement following treatment of acquired cold urticaria by prednisone. Br J Clin Pharmacol 12:327–331PubMedGoogle Scholar
  5. Black AK, Hensby CN, Greaves MW (1982a) Increased levels of 6-oxo-PGFlα in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 13:351–354PubMedGoogle Scholar
  6. Black AK, Greaves MW, Hensby CN (1982b) The effect of systemic prednisolone on arachidonic acid and prostaglandin E2 and F2α levels in human cutaneous inflammation. Br J Clin Pharmacol 14:391–394Google Scholar
  7. Borgeat P, Samuelsson B (1979) Arachidonic acid metabolism in polymorphonuclear leucocytes:effects of ionophore A23187. Proc Natl Acad Sci USA 76:2148–2155PubMedCrossRefGoogle Scholar
  8. Brain SD, Camp RDR, Dowd PM, Greaves MW, Black AK, Mallet AI, Greaves MW (1982) Psoriasis and leukotriene B4. Lancet II:762CrossRefGoogle Scholar
  9. Camp RD, Greaves MW, Hensby CN, Plummer NA, Warin AP (1978) Irradiation of human skin by short wavelength ultraviolet radiation (100–290 nm) (UV-C):increased concentrations of arachidonic acid and prostaglandins E2 and F. Br J Clin Pharmacol 6:145–148PubMedGoogle Scholar
  10. Camp RDR, Coutts AA, Greaves MW, Kay AB, Walport MJ (1982) Responses of human skin to intradermal injection of leukotrienes C4, D4, and B4. Br J Pharmacol 80:497–502Google Scholar
  11. Camp RDR, Russel-Jones R, Brain S, Wollard P, Greaves MW (1984) Production of intraepidermal microabscesses by topical application of leueotriene B4. J Invest Dermatol 82:202–204PubMedCrossRefGoogle Scholar
  12. Chan SC, Greive SR, Sagko MJ, Hanigin JM (1981) Enhanced leukocyte phosphodies-terase activity in atopic dermatitis and after histamine-mediated desensitisation. Clin Res 29:597 (Abstract)Google Scholar
  13. Cook J, Shuster S (1980) Histamine weal formation and absorption in man. Br J Pharmacol 69:579–585PubMedGoogle Scholar
  14. Craps L, Inderbitzin T (1957) Histamine cutanee et reactions inflammatories. Arch Beiges Dermatol 13:1–19Google Scholar
  15. Czarnetzki B, Kern F, Lichtenstein LM (1976) Defective release of eosinophil chemotactic factor from peripheral leucocytes in patients with chronic urticaria. J Invest Dermatol 67:276–278PubMedCrossRefGoogle Scholar
  16. Dale HH (1934) Progress in autopharmacology. A survey of present knowledge of the chemical regulation of certain functions by natural constituents of the tissues. I. Introduction. The action of histamine and evidence restricting its possible significance. Evidence for other natural vasodilators. Bull Johns Hopkins Hosp 53:297–307Google Scholar
  17. Dunsky EH, Zweiman B (1978) The direct demonstration of histamine release in allergic reactions in the skin using a skin chamber technique. J Allergy Clin Immunol 62:127–130PubMedCrossRefGoogle Scholar
  18. Dvorak HF, Mihm JC (1972) Basophil leukocytes in allergic contact dermatitis. J Exp Med 135:235–254PubMedCrossRefGoogle Scholar
  19. Eaglestein WH, Marsico AR (1975) Dichotomy in response to indomethacin in UV-C and UV-B induced ultraviolet light inflammation. J Invest Dermatol 65:238–240CrossRefGoogle Scholar
  20. Epstein JH, Winkelmann RK (1967) Ultraviolet light induced kinin formation in human skin. Arch Dermatol 95:532–535PubMedCrossRefGoogle Scholar
  21. Everett MA, Yeargers E, Sayre RM, Olson RC (1966) Penetration of epidermis by ultraviolet rays. Photochem Photobiol 5:533–542PubMedCrossRefGoogle Scholar
  22. Goldyne ME, Winkelmann RK, Ryan RJ (1973) Prostaglandin activity in human cutaneous inflammation:detection by radioimmunoassay. Prostaglandins 4:737–749PubMedCrossRefGoogle Scholar
  23. Goodwin LG, Jones CR, Richards WHG, Kohn J (1963) Pharmacologically active substances in the urine of burned patients. Br J Exp Pathol 44:551–560PubMedGoogle Scholar
  24. Graham HT, Lowry OH, Wheelwright F, Lenz M, Parish HH (1955) Distribution of histamine among leukocytes and platelets. Blood 10:467–475PubMedGoogle Scholar
  25. Greaves MW, Søndergaard J (1970 a) Urticaria pigmentosa and factitious urticaria: direct evidence for release of histamine and other smooth muscle contracting agents in der- mographic skin. Arch Dermatol 101:418–425PubMedCrossRefGoogle Scholar
  26. Greaves MW, Søndergaard J (1970 b) A new pharmacological finding in human allergic contact eczema. Arch Dermatol 101:659–661PubMedCrossRefGoogle Scholar
  27. Greaves MW, Søndergaard J, McDonald-Gibson W (1971) Recovery of prostaglandins in human cutaneous inflammation. Br Med J [Clin Res] 2:258–260CrossRefGoogle Scholar
  28. Greaves MW, Plummer VM, McLaughlan P, Stanworth DR (1974) Serum and cell-bound IgE in chronic urticaria. Clin Allergy 4:265–271PubMedCrossRefGoogle Scholar
  29. Gschnait F, Pehamberger H (1977) Indomethacin does not affect PUVA induced erythema. Arch Dermatol Res 259:109–111PubMedCrossRefGoogle Scholar
  30. Hawk JLM, Black AK, Jaenicke KF, Barr RM, Soter N, Mallet AI, Gilchrest BA, Hensby CN, Parish J A, Greaves MW (1983) Increased concentrations of arachidonic acid, prostaglandins E2, D2, 6-oxo-F and histamine in human skin following ultraviolet A irradiation. J Invest Dermatol 80:496–499PubMedCrossRefGoogle Scholar
  31. Heiligstadt H, Kassis V, Wiesmann K, Sondergaard J (1978) Prostaglandins in PUVA-treated psoriasis. Acta Derm Venereol (Stockh) 58:213–216Google Scholar
  32. Hemels HG (1970) The effect of propranolol on the acetyl choline-induced sweat response in atopic and non-atopic subjects. Br J Dermatol 83:312–315PubMedCrossRefGoogle Scholar
  33. Johansson SA (1960) 5-Hydroxytryptamine in burns. Acta Physiol Scand 48:126–131PubMedCrossRefGoogle Scholar
  34. Johnson BE, Daniels F (1969) Lysosomes and reactions of the skin to ultraviolet radiation. J Invest Dermatol 53:85–89PubMedGoogle Scholar
  35. Johnson HH, De Oreo GA, Lascheid WB, Mitchell F (1960) Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 34:237–241PubMedGoogle Scholar
  36. Kaidby KH, Kligman AM (1979) The acute effects of long wavelength ultraviolet on human skin. J Invest Dermatol 72:253–256CrossRefGoogle Scholar
  37. Kaplan AP, Horakova Z, Katz SI (1978) Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 61:350–354PubMedCrossRefGoogle Scholar
  38. Katz G, Cohen S (1941) Experimental evidence for histamine release in allergy. JAMA 117:1782–1783Google Scholar
  39. Keahey TM, Greaves MW (1980) Cold urticaria:disassociation of cold-evoked histamine release and urticaria following cold challenge. Arch Dermatol 116:174–177PubMedCrossRefGoogle Scholar
  40. Kern F, Lichtenstein LM (1976) Defective histamine release in chronic urticaria. J Clin Invest 57:1369–1377PubMedCrossRefGoogle Scholar
  41. Lawrence CM, Jorizzo JL, Black AK, Coutts A, Greaves MW (1981) Cholinergic urticarial with associated angio-oedema. Br J Dermatol 105:543–550PubMedCrossRefGoogle Scholar
  42. Lazarus GS, Yost FJ, Thomas CA (1977) Polymorphonuclear leucocytes:possible mechanism of accumulation in psoriasis. Science 198:1162–1163PubMedCrossRefGoogle Scholar
  43. Lewis T (1927) Blood vessels of the human skin and their responses. Shaw, LondonGoogle Scholar
  44. Lewis T, Grant RT (1924) Vascular reactions of the skin to injury. II. The liberation of histamine-like substance in injured skin:the underlying cause of factitious urticaria and of weals produced by burning; and the observations upon the nervous control of certain skin reactions. Heart 2:209–265Google Scholar
  45. Michaelsson G (1970) Decreased cutaneous reactions to kallikrein in patients with atopic dermatitis and psoriasis. Acta Derm Venereol (Stockh) 50:37–44Google Scholar
  46. Mihm MC, Soter NA, Dvorak HF, Austen KF (1976) The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67:305–312PubMedCrossRefGoogle Scholar
  47. Mikhail GR, Miller-Milinska A (1964) Mast cell population in human skin. J Invest Dermatol 43:249–253PubMedGoogle Scholar
  48. Misch KJ, Black AK, Barr R, Hensby CN, Mallet AI, Greaves MW (1982) Histamine and non-histamine pharmacological activity in cold urticaria. J Invest Dermatol 78:329 (Abstract)Google Scholar
  49. Misch KJ, Black AK, Barr RM, Greaves MW (in preparation) Arachidonic acid lipoxygenase products in contact allergic dermatitisGoogle Scholar
  50. Partington MW (1954) The vascular response of skin to ultraviolet light. Clin Sci 13:425–430PubMedGoogle Scholar
  51. Phanuphak P, Schocket AL, Arroyave CM, Kohler PF (1980) Skin histamine in chronic urticaria. J Allergy Clin Immunol 65:371–375PubMedCrossRefGoogle Scholar
  52. Pick E, Krejci J, Turk JL (1969) Interaction between sensitised lymphocytes and antigen in vitro. I. The release of a skin reactive factor. Immunology 17:741–767PubMedGoogle Scholar
  53. Plummer NA, Hensby CN, Black AK, Greaves MW (1977) Prostaglandin activity in sustained inflammation of human skin before and after aspirin. Clin Sci Mol Med 52:615–620PubMedGoogle Scholar
  54. Plummer NA, Hensby CN, Warin AP, Camp RDR, Greaves MW (1978) Prostaglandins E2, F2 and arachidonic acid levels in irradiated and unirradiated skin of psoriatic pa-tients receiving PUVA treatment. Clin Exp Dermatol 3:367–369PubMedCrossRefGoogle Scholar
  55. Ring J, Allen DH, Mathison DA, Spiegelberg HL (1980) In vitro releasibility of histamine and serotonin:studies of atopic patients. J Clin Immunol 3:85–91Google Scholar
  56. Rocklin RE (1976) Modulation of cellular immune responses in vivo and in vitro by his-tamine receptor-bearing lymphocytes. J Clin Invest 57:1051–1057PubMedCrossRefGoogle Scholar
  57. Sibbald RG, Black AK, Eady RAJ, James M, Greaves MW (1981) Aquagenic urticaria:evidence of cholinergic and histaminergic basis. Br J Dermatol 105:297–301PubMedCrossRefGoogle Scholar
  58. Søndergaard J, Greaves MW (1970) Pharmacological studies in inflammation due to ultraviolet radiation. J Pathol 101:93–97PubMedCrossRefGoogle Scholar
  59. Søndergaard JS, Greaves MW (1971) Direct recovery of histamine from cutaneous anaphylaxis in man. Acta Derm Venereol (Stockh) 51:98–100Google Scholar
  60. Søndergaard JS, Greaves MW (1974) Recovery of prostaglandins in human primary irritant dermatitis. Arch Dermatol 110:556–558PubMedCrossRefGoogle Scholar
  61. Strehler E (1949) Über die Wirkungsweise eines neuen Hauthyperämiemittels Trafuril (Nikotinsäuretetrahydrofurfurylester). Schweiz Med Wochenschr 79:144–152PubMedGoogle Scholar
  62. Szentivanyi A (1979) The conformational flexibility of adrenoreceptors and the constitutional basis of atopy. Triangle 18:109–115PubMedGoogle Scholar
  63. Tagami H, Ofuji S (1976) Leucotactic properties of soluble substances in psoriasis scale. Br J Dermatol 95:1–8PubMedCrossRefGoogle Scholar
  64. Tagami H, Ofuji S (1977) Characterisation of a leucotactic factor derived from psoriatic scale. Br J Dermatol 97:509–518PubMedCrossRefGoogle Scholar
  65. Ting S, Dunsky EH, Lavker RM, Zweiman B (1980) Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. J Allergy 66:417–423Google Scholar
  66. Truelove LH, Duthie JJ (1959) Effect of aspirin on the cutaneous response to local application of an ester of nicotinic acid. Ann Rheum Dis 18:137–141PubMedCrossRefGoogle Scholar
  67. Van der Leun JC (1966) Ultraviolet erythema:a study on diffusion processes in human skin. PhD thesis, Utrecht, NetherlandsGoogle Scholar
  68. Vane JR (1964) The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol 23:360–373Google Scholar
  69. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirinlike drugs. Nature New Biol 231:232–235PubMedGoogle Scholar
  70. Williams TJ, Morley J (1973) Prostaglandins as potientiators of increased vascular permeability. Nature 246:215–217PubMedCrossRefGoogle Scholar
  71. Willoughby DA, Walter MN, Spector WG (1965) Lymph node permeability factor in dinitrochlorbenzene skin hypersensitivity reaction in guinea pigs. Immunology 8:578–584PubMedGoogle Scholar
  72. Winkelmann RK (1966 a) Technique of dermal perfusion. J Invest Dermatol 46:220–284PubMedGoogle Scholar
  73. Winkelmann RK (1966 b) Non-allergic factors in atopic dermatitis. J Allergy 37:29–37PubMedCrossRefGoogle Scholar
  74. Winkelmann RK, Wilhelmj CM, Horner FA (1965) Experimental studies on dermographism. Arch Dermatol 92:436–442PubMedCrossRefGoogle Scholar
  75. Wolf-Jurgensen P (1966) Basophil leucocytes in delayed hypersensitivity:experimental studies in man using the skin window technique. Munksgaard, CopenhagenGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. W. Greaves
  • F. Lawlor

There are no affiliations available

Personalised recommendations